Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Sarclisa plus KRd significantly improved rate of minimal residual disease negativity in transplant-eligible patients with newly diagnosed multiple myeloma versus KRd alone: Sanofi

Ruchika Sharma11 Dec 2023 2:30 PM IST

Paris: Sanofi has announced that the Phase 3 trial investigating Sarclisa (isatuximab) in combination with carfilzomib, lenalidomide and...

Zydus, Daewoong Pharma collaborate to co-develop, commercialise Leuprolide Long-Acting Injectable in US

Ruchika Sharma11 Dec 2023 12:30 PM IST

Leuprolide acetate for depot suspension is a gonadotropin-releasing hormone (GnRH) agonist, a long-acting injectable product in a kit with a prefilled...

Natco Pharma gets 7 USFDA observations for Kothur Pharma Division

Intas Pharma gets USFDA warning letter due to manufacturing lapses at Ahmedabad plant

Ruchika Sharma11 Dec 2023 11:30 AM IST

"Repeated failures demonstrate that executive management oversight and control over the manufacture of drugs is inadequate," USFDA said.

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck announces positive results from phase 2 trial evaluating coformulation of vibostolimab, pembrolizumab in lung cancer patients

Ruchika Sharma10 Dec 2023 2:00 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced full results from the non-registrational Phase 2 KeyVibe-002...

Novo Nordisk Wegovy approved by USFDA for adults with noncirrhotic MASH with liver fibrosis

Ozempic side effects lawsuit can move forward

Ruchika Sharma10 Dec 2023 12:30 PM IST

A Louisiana federal judge on Friday largely rejected Novo Nordisk’s bid to dismiss one of the earliest lawsuits brought against the pharmaceutical...

Sanofi gets approval for 2 rare hematologic diseases medicines in China

Sanofi multiple myeloma drug Sarclisa phase 3 trial meets primary endpoint of progression-free survival

Ruchika Sharma10 Dec 2023 11:30 AM IST

Paris: Sanofi has announced that the Phase 3 IMROZ trial evaluating the investigational use of Sarclisa (isatuximab) in combination with...

Bayer, Salus Optima collaborate on AI-Enabled Healthy Aging Journey

Ruchika Sharma10 Dec 2023 10:00 AM IST

London: Salus Optima, a provider of AI-enabled digital health and wellness solutions, and the Consumer Health division of Bayer have launched a...

Over 15000 Jan Aushadhi Kendras opened till last month under PMBJP scheme across country: Minister

Jan Aushadhi scheme has led to savings of Rs 7416 cr for citizens this fiscal: Govt

Ruchika Sharma9 Dec 2023 3:45 PM IST

The projected sales target for 2023-24 is Rs 1,400 crore and the scheme is growing at a very fast pace garnering public trust and confidence, Khuba...

Abbvie gets USFDA approval for updated indication statement for Rinvoq for Inflammatory Bowel Disease

AbbVie to focus on smaller deals after buying spree

Ruchika Sharma9 Dec 2023 2:30 PM IST

AbbVie said it expects to return to "robust growth" in 2025, after its recent buying spree.

Merck-Eisai endometrial cancer therapy combo fails first-line treatment trial

Ruchika Sharma9 Dec 2023 1:30 PM IST

Rahway: Merck said on Friday a combination therapy being developed with partner Eisai failed a late-stage trial testing it as a first-line...

Pfizer discontinues development of danuglipron for chronic weight management

Pfizer Elrexfio gets European Commission approval for Multiple Myeloma

Ruchika Sharma9 Dec 2023 12:00 PM IST

The conditional marketing authorization for ELREXFIO is valid in all 27 EU member states as well as Iceland, Liechtenstein, and Norway.

Dr Reddys Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, Europe

Dr Reddy's Labs gets 3 USFDA observations for Bachupally RnD centre

Ruchika Sharma9 Dec 2023 10:57 AM IST

Hyderabad: Drug major Dr Reddy's Labs, has announced that the United States Food & Drug Administration (USFDA) has issued three...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok